Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$47.37 - $90.04 $54.1 Million - $103 Million
-1,141,390 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$53.13 - $71.19 $25.3 Million - $34 Million
477,000 Added 71.8%
1,141,390 $68 Million
Q3 2019

Nov 14, 2019

BUY
$57.11 - $73.3 $5.35 Million - $6.86 Million
93,600 Added 16.4%
664,390 $39.2 Million
Q2 2019

Aug 14, 2019

SELL
$54.41 - $71.7 $3.29 Million - $4.34 Million
-60,510 Reduced 9.58%
570,790 $36.8 Million
Q1 2019

May 15, 2019

SELL
$32.25 - $73.56 $10.2 Million - $23.3 Million
-316,700 Reduced 33.41%
631,300 $40.1 Million
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $6.64 Million - $9.49 Million
233,500 Added 32.68%
948,000 $36 Million
Q3 2018

Nov 14, 2018

SELL
$21.39 - $51.17 $20.8 Million - $49.9 Million
-974,500 Reduced 57.7%
714,500 $30.6 Million
Q2 2018

Aug 14, 2018

BUY
$4.9 - $23.64 $8.28 Million - $39.9 Million
1,689,000 New
1,689,000 $37.2 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.98B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.